Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,823 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors.
Suzuki H, Iwamoto H, Seki T, Nakamura T, Masuda A, Sakaue T, Tanaka T, Imamura Y, Niizeki T, Nakano M, Shimose S, Shirono T, Noda Y, Kamachi N, Sakai M, Morita K, Nakayama M, Yoshizumi T, Kuromatsu R, Yano H, Cao Y, Koga H, Torimura T. Suzuki H, et al. Among authors: imamura y. Cancer Commun (Lond). 2023 Apr;43(4):415-434. doi: 10.1002/cac2.12411. Epub 2023 Feb 24. Cancer Commun (Lond). 2023. PMID: 36825684 Free PMC article.
Ex vivo expansion of circulating CD34(+) cells enhances the regenerative effect on rat liver cirrhosis.
Nakamura T, Koga H, Iwamoto H, Tsutsumi V, Imamura Y, Naitou M, Masuda A, Ikezono Y, Abe M, Wada F, Sakaue T, Ueno T, Ii M, Alev C, Kawamoto A, Asahara T, Torimura T. Nakamura T, et al. Among authors: imamura y. Mol Ther Methods Clin Dev. 2016 Apr 27;3:16025. doi: 10.1038/mtm.2016.25. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 27162932 Free PMC article.
A tumor endothelial cell-specific microRNA replacement therapy for hepatocellular carcinoma.
Iwamoto H, Suzuki H, Masuda A, Sakaue T, Nakamura T, Tanaka T, Sakai M, Imamura Y, Yano H, Torimura T, Koga H, Yasuda K, Tsurusaki M, Seki T, Kawaguchi T. Iwamoto H, et al. Among authors: imamura y. iScience. 2024 Jan 4;27(2):108797. doi: 10.1016/j.isci.2024.108797. eCollection 2024 Feb 16. iScience. 2024. PMID: 38303694 Free PMC article.
Cytokine-inducing macromolecular glycolipids from Enterococcus hirae: improved method for separation and analysis of its effects on cellular activation.
Hashimoto M, Imamura Y, Morichika T, Arimoto K, Takeuchi O, Takeda K, Akira S, Aoyama K, Tamura T, Kotani S, Suda Y, Kusumoto S. Hashimoto M, et al. Among authors: imamura y. Biochem Biophys Res Commun. 2000 Jun 24;273(1):164-9. doi: 10.1006/bbrc.2000.2921. Biochem Biophys Res Commun. 2000. PMID: 10873580
Programmed Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor and Monitor of Response to Atezolizumab plus Bevacizumab Treatment in Patients with Hepatocellular Carcinoma.
Nosaka T, Murata Y, Akazawa Y, Tanaka T, Takahashi K, Naito T, Matsuda H, Ohtani M, Imamura Y, Nakamoto Y. Nosaka T, et al. Among authors: imamura y. Cancers (Basel). 2024 May 6;16(9):1785. doi: 10.3390/cancers16091785. Cancers (Basel). 2024. PMID: 38730737 Free PMC article.
1,823 results